A partnership to improve heart failure treatment and clinical trials.
The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community
The Heart Failure Collaboratory is working together with patients, researchers, and industry experts to make it easier and faster to develop new treatments for heart failure, so that people living with this condition can have better options and outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Inova Health Care Services NIH-funded |
| Lab location | 1 site (Fairfax, UNITED STATES) |
| Project ID | NIH-10823250 on NIH RePORTER |
What this research studies
The Heart Failure Collaboratory (HFC) is a collaboration between the Inova Heart and Vascular Institute, the FDA, and various stakeholders in the heart failure community. This initiative aims to enhance the efficiency of clinical trials and the development of new therapies for heart failure by fostering collaboration among patients, researchers, and industry representatives. The HFC focuses on addressing challenges in the heart failure ecosystem, such as refining clinical trial endpoints and standardizing data collection. By creating a supportive environment for innovation, the HFC seeks to improve patient outcomes and accelerate the introduction of effective treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with heart failure who are interested in participating in clinical trials or benefiting from new treatment developments.
Not a fit: Patients with conditions unrelated to heart failure may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective heart failure therapies and improved clinical trial processes.
How similar studies have performed: Other collaborative efforts in the medical field have shown success in improving clinical trial efficiency and therapeutic development, indicating a promising approach.
Where this research is happening
Fairfax, UNITED STATES
- Inova Health Care Services — Fairfax, United States (Active)
Researchers
- Principal investigator: O'connor, Christopher M — Inova Health Care Services
- Study coordinator: O'connor, Christopher M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.